Skip to main content
. 2023 May 18;15(5):1524. doi: 10.3390/pharmaceutics15051524

Table 5.

Within- and between-run A & P of the method in DBS.

Analyte Nominal Concentration (ng/mL) Within-Run (n = 5) Between-Run (n = 15)
Mean Concentration (ng/mL) CV% Acc% Mean Concentration (ng/mL) CV% Acc%
rucaparib 100 95 6 95 96 5 96
255 255 3 100 258 3 101
1700 1784 3 105 1761 3 104
4250 4402 4 104 4353 5 102
niraparib 60 60 3 101 59 4 98
153 149 2 98 149 3 97
1020 1026 3 101 1009 3 99
2460 2483 3 97 2418 3 95
olaparib 140 132 2 94 140 5 100
357 338 2 95 350 4 98
2380 2373 2 100 2376 3 100
5950 5859 1 98 5918 3 99

Acc%, percentage of accuracy; CV%, coefficient of variation; n, number of replicates.